PMV PHARMACEUTICALS INC shareholders Q2 2023

PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.

PMV PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,614,911$10,109,34341.23%
OUP Management Co., LLC 989,232$6,192,59210.56%
Euclidean Capital LLC 2,545,242$15,933,2154.09%
Nextech Invest Ltd. 471,284$2,950,2381.00%
Mesirow Financial Investment Management, Inc. 34,748$217,5220.92%
Boxer Capital, LLC 3,163,795$19,8050.92%
Orbimed Advisors 6,563,077$41,084,8620.74%
Ghost Tree Capital, LLC 280,981$1,758,9410.58%
PERSONAL CFO SOLUTIONS, LLC 350,342$2,193,1410.44%
Octagon Capital Advisors LP 470,000$2,942,2000.41%
Tri Locum Partners LP 158,413$991,6650.37%
RTW INVESTMENTS, LP 3,029,551$18,964,9890.36%
SECTORAL ASSET MANAGEMENT INC 332,250$2,079,8850.35%
Avoro Capital Advisors LLC 3,060,000$19,155,6000.26%
Verition Fund Management LLC 2,364,196$14,799,8670.20%
SPHERA FUNDS MANAGEMENT LTD. 187,800$1,175,6280.18%
GSA CAPITAL PARTNERS LLP 114,604$7170.07%
DENALI ADVISORS LLC 30,500$190,9300.07%
Virtus ETF Advisers LLC 18,184$113,8320.07%
PFM Health Sciences, LP 228,410$1,429,8470.06%
External links

This page lists PMV PHARMACEUTICALS INC's shareholders in Q2 2023. To view PMV PHARMACEUTICALS INC's shareholder history, click here.